BPA

The European Society of Pathology (ESP) in close collaboration with the UEMS Board of Pathology announces the 2021 Pathology Progress Test (PPT).  From 24th of November until 10th of December 2021 those interested are invited to take the PPT, which is primarily intended for trainees, but any pathologist curious to submit her or his knowledge base to the test is welcome to participate. The test consists of 120 questions, in a multiple-choice question (MCQ) format. The questions are partly only text, partly still…

The European Society of Pathology (ESP) in close collaboration with the UEMS Board of Pathology has announced the 2021 Pathology Progress Test (PPT).  To allow our colleagues a few more days to prepare for the PPT, it has been decided to move the start date to Wednesday, 24 November 2021. The total period of time when the PPT will be available has been exteded by two days, being now available until Friday, 10 December. We would like to take this opportunity to remind the Colleagues who are…

Invitation for participation The European Society of Pathology (ESP) Foundation is continuing the successful organisation of External Quality Assurance (EQA) Programmes.  We invite colleagues and laboratories interested in Colorectal Carcinomas EQA to register for this Scheme. Registrations are open until 1 February 2022.  More information can be found in the attached flyer.

The European Commision (EC) has proposed a progressive roll-out of the new In Vitro Diagnostic Medical Devices Regulation to prevent disruption in the supply of these essential healthcare products. The ESP would like to draw your attention to this essential press release of EC (14 October 2021) and invite you to disseminate this information among your Colleagues. Please visit the link In Vitro Diagnostic Devices Regulation (europa.eu). Sincerely,European Society of Pathology

The European Commission (EC) has proposed a progressive roll-out of the new In Vitro Diagnostic Medical Devices Regulation to prevent disruption in the supply of these essential healthcare products. The ESP would like to draw your attention to this essential press release of EC (14 October 2021) and invite you to disseminate this information to your colleagues and members of the national society. Please visit the link In Vitro Diagnostic Medical Devices Regulation (europa.eu)

Digital Microscopy and AI Clinical and Research Applications West Medica feels strongly that innovation is the key to a brighter future and improves the quality of life for everyone. Development of Vision solutions for digital microscopy is a top priority and the main focus of West Medica. Technology is an increasingly influential factor in many fields as new methods are established every day and that’s the reason why West Medica always tries to be one-step ahead. New analytical procedures are…